Currently, Neuralieve is trying to get its hand-held sTMS device approved by the FDA to be able to market it commercially.

"This was our first pivotal study, and the results are quite good," says Baker. "It showed significant effects."


Going forward, Lipton says he would love to try this study on migraine sufferers who don't experience auras. Based on previous research, he thinks it would be successful.

"There's a fairly good chance that the treatment will work, based on prior studies using table-top devices that show in people without aura, they can treat and relieve pain," Lipton says.

Lipton also wants to study when patients feel relief after using the device - five, 10, 20 minutes after treatment - as this study recorded pain relief only after two hours, four hours, 24 hours and 48 hours.

These results are promising for finding another type of treatment for migraine sufferers. With 30 million American sufferers, there is no "one-size-fits-all" treatment, says Lipton.

This treatment in particular appeals to migraine sufferers who try to avoid taking medications, be it preventive or for pain relief.

"I love the idea of using a magnetic device [to treat migraines]," says Lipton. "For me, it's all about safety and efficacy. I don't care if it's an herb, device, drug - what I want to know is that what people are using is safe and effective."

Back to HCB News

More Industry Headlines